These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Familial hypercholesterolemia: Detect, treat, and ask about family. Shah NP; Ahmed HM; Wilson Tang WH Cleve Clin J Med; 2020 Feb; 87(2):109-120. PubMed ID: 32015064 [TBL] [Abstract][Full Text] [Related]
8. Development of a motivational interviewing genetic counseling intervention to increase cascade cholesterol screening in families of children with familial hypercholesterolemia. Kruger V; Redlinger-Grosse K; Walters ST; Ash E; Cragun D; McCarthy Veach P; Zierhut HA J Genet Couns; 2019 Oct; 28(5):1059-1064. PubMed ID: 31273864 [No Abstract] [Full Text] [Related]
9. Familial Hypercholesterolemia: A Reportable Disorder. Kullo IJ Circulation; 2020 Nov; 142(21):1999-2001. PubMed ID: 33226870 [No Abstract] [Full Text] [Related]
10. Identification of people with heterozygous familial hypercholesterolemia. Haase A; Goldberg AC Curr Opin Lipidol; 2012 Aug; 23(4):282-9. PubMed ID: 22801386 [TBL] [Abstract][Full Text] [Related]
11. Lessening the Burden of Familial Hypercholesterolemia Using Health Information Technology. Safarova MS; Kullo IJ Circ Res; 2018 Jan; 122(1):26-27. PubMed ID: 29301842 [No Abstract] [Full Text] [Related]
12. The Roles of Genetic Analysis in the Diagnosis of Pediatric Patients with Familial Hypercholesterolemia. Harada-Shiba M J Atheroscler Thromb; 2022 May; 29(5):575-576. PubMed ID: 35249907 [No Abstract] [Full Text] [Related]
13. [Genetic screening for a pedigree of familial hypercholesterolemia]. Zhu F; Zhong YC; Wang C; Zhang FX; Wang M; Dong SL; Wang X; Cheng X Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Feb; 50(2):185-188. PubMed ID: 35172466 [TBL] [Abstract][Full Text] [Related]
14. The role of registries and genetic databases in familial hypercholesterolemia. Kindt I; Mata P; Knowles JW Curr Opin Lipidol; 2017 Apr; 28(2):152-160. PubMed ID: 28169870 [TBL] [Abstract][Full Text] [Related]
15. Familial Hypercholesterolemia in Children and Adolescents: Diagnosis and Treatment. Maliachova O; Stabouli S Curr Pharm Des; 2018; 24(31):3672-3677. PubMed ID: 30317987 [TBL] [Abstract][Full Text] [Related]
16. The treatment of heterozygous familial hypercholesterolemia - a local perspective. Bułdak Ł Endokrynol Pol; 2021; 72(3):189-190. PubMed ID: 34292576 [TBL] [Abstract][Full Text] [Related]
17. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk. Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017 [TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and treatment of familial hypercholesterolemia in children and adolescents]. Ose L; Tonstad S; Vesterhus P; Wefring KW Tidsskr Nor Laegeforen; 1995 Nov; 115(28):3499-503. PubMed ID: 7491603 [TBL] [Abstract][Full Text] [Related]
19. Evolocumab in the management of children <10 years of age affected by homozygous familial hypercholesterolemia. Buonuomo PS; Mastrogiorgio G; Leone G; Rana I; Gonfiantini MV; Macchiaiolo M; Vecchio D; Gnazzo M; Bartuli A Atherosclerosis; 2021 May; 324():148-150. PubMed ID: 33824001 [No Abstract] [Full Text] [Related]
20. Cholesterol and family history: when genetics matters. Vengoechea J; McKelvey KD J Ark Med Soc; 2015 Feb; 111(9):184-6. PubMed ID: 25993767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]